首页 | 本学科首页   官方微博 | 高级检索  
检索        


Impact of antiandrogen withdrawal syndrome in castration-resistant prostate cancer patients treated with abiraterone or enzalutamide
Authors:Masaki Shiota  Asako Machidori  Tatsuro Abe  Keisuke Monji  Eiji Kashiwagi  Ario Takeuchi  Ryosuke Takahashi  Junichi Inokuchi  Akira Yokomizo  Seiji Naito  Masatoshi Eto
Institution:1. Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan;2. Department of Urology, Harasanshin Hospital, Fukuoka, Japan
Abstract:
Keywords:abiraterone  androgen receptor  antiandrogen withdrawal syndrome  castration-resistant prostate cancer  enzalutamide
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号